Year: 2018
Type: review
Abstract: During an ST-elevation myocardial infarction (STEMI), the myocardium undergoes a prolonged period of ischaemia. Reperfusion therapy is essential to minimize cardiac injury but can paradoxically cause further damage. Experimental procedures to limit ischaemia and reperfusion (IR) injury have tended to focus on the cardiomyocytes since they are crucial for cardiac function. However, there is increasing evidence that non-cardiomyocyte resident cells in the heart (as discussed in a separate review in this Spotlight series) as well as circulating cells and factors play important roles in this pathology. For example, erythrocytes, in addition to their main oxygen-ferrying role, can protect the heart from IR injury via the export of nitric oxide bioactivity. Platelets are well-known to be involved in haemostasis and thrombosis, but beyond these roles, they secrete numerous factors including sphingosine-1 phosphate (S1P), platelet activating factor, and cytokines that can all strongly influence the development of IR injury. This is particularly relevant given that most STEMI patients receive at least one type of platelet inhibitor. Moreover, there are large numbers of circulating vesicles in the blood, including microvesicles and exosomes, which can exert both beneficial and detrimental effects on IR injury. Some of these effects are mediated by the transfer of microRNA (miRNA) to the heart. Synthetic miRNA molecules may offer an alternative approach to limiting the response to IR injury. We discuss these and other circulating factors, focussing on potential therapeutic targets relevant to IR injury. Given the prevalence of comorbidities such as diabetes in the target patient population, their influence will also be discussed. This article is part of a Cardiovascular Research Spotlight Issue entitled 'Cardioprotection Beyond the Cardiomyocyte', and emerged as part of the discussions of the European Union (EU)-CARDIOPROTECTION Cooperation in Science and Technology (COST) Action, CA16225.
Source: Cardiovascular Research
DOI: 10.1093/cvr/cvy314
Institutions: University College London, National and Kapodistrian University of Athens, Swiss Institute for Regenerative Medicine, Istituto Cardiocentro Ticino, Baylor College of Medicine, Justus-Liebig-Universität Gießen, Kazan Federal University, Duke-NUS Medical School, National Heart Centre Singapore, Tecnológico de Monterrey, University of South Alabama, University of Coimbra, Istituto Nazionale per le Ricerche Cardiovascolari, University of Turin, Karolinska University Hospital, Karolinska Institutet, Semmelweis University, Pharmahungary Group (Hungary)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: ST-elevation myocardial infarction, ischemia-reperfusion injury, cardioprotection, circulating blood cells, extracellular vesicles, erythrocytes, nitric oxide, platelets, sphingosine-1-phosphate, platelet-activating factor, microvesicles, exosomes, microRNA transfer, synthetic microRNA, antiplatelet agents, diabetes comorbidity
Open Access status: hybrid
Estimated APC paid: $5,329
Funders: Boehringer Ingelheim, Von-Behring-Röntgen-Stiftung, National Institute for Health and Care Research, British Heart Foundation, University College London, European Cooperation in Science and Technology, Deutsche Forschungsgemeinschaft, Semmelweis Egyetem, Hungarian Scientific Research Fund, Emberi Eroforrások Minisztériuma, Università degli Studi di Torino, Nemzeti Kutatási Fejlesztési és Innovációs Hivatal, Servier, Kazan Federal University, EU-CARDIOPROTECTION, Medical Research Council, Fundação para a Ciência e a Tecnologia, European Regional Development Fund
Awards: G1063523350, G1098268392, G1167214205, G1513026599, G1516346500, G1577006909, G1578237752, G1694240431, G1738013897, G1763632427, G182692708, G193747123, G1951474629, G196013823, G2294835626, G245083819, G2490703178, G2558690399, G2743565462, UID/NEU/04539 .: CNC.IBILI, Exosomes - circulating cardioprotective nanoparticles, G3728671807, G3840324753, G3907702963, CNC. IBILI, G4349736526, G4372957208, G4724859719, G5131612158, G5224927334, G5454278309, G5613220980, G5677667711, HealthyAging2020, NIHR Senior Investigator Award, Protecting the heart with a novel activator of the RISK pathway, How do the class I PI3K isoforms contribute to reperfusion injury and ischaemic preconditioning?
OpenAlex ID: W2906459748
